41 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
29
Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1).
University of California
1
Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.
Kanazawa University
4
The cation transporters rOCT1 and rOCT2 interact with bicarbonate but play only a minor role for amantadine uptake into rat renal proximal tubules.
University of Manitoba
1
The synthesis and biodistribution of [(11)C]metformin as a PET probe to study hepatobiliary transport mediated by the multi-drug and toxin extrusion transporter 1 (MATE1) in vivo.
Riken Center For Life Science Technologies
62
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
University of California
15
Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1.
Institute of Anatomy of The Bayerische Julius-Maximilians-Universit£T
3
Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney.
Tokyo University of Science
4
Molecular mechanisms of organic cation transport in OCT2-expressing Xenopus oocytes.
Kyoto University Hospital
6
Functional characterization of mouse cation transporter mOCT2 compared with mOCT1.
Kyushu University
6
Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2).
University of California
4
Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1).
University of California
8
Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.
University of Bonn
8
Transport of small organic cations in the rat liver. The role of the organic cation transporter OCT1.
University of Heidelberg
13
Drug excretion mediated by a new prototype of polyspecific transporter.
Bayerische Julius-Maximilians-Universit£T
1
Agmatine is efficiently transported by non-neuronal monoamine transporters extraneuronal monoamine transporter (EMT) and organic cation transporter 2 (OCT2).
University of Cologne
1
Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1.
University of Arizona
17
Distinct characteristics of organic cation transporters, OCT1 and OCT2, in the basolateral membrane of renal tubules.
Kyoto University Hospital
7
Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.
Kyoto University Hospital
7
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.
University of California San Francisco
2
Role of organic cation transporters in the renal secretion of nucleosides.
The University of Texas M.D. Anderson Cancer Center
44
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Uppsala University
13
Discovery of First Branched-Chain Ketoacid Dehydrogenase Kinase (BDK) Inhibitor Clinical Candidate PF-07328948.
Pfizer Inc.
2
The Discovery and Preclinical Profile of ALG-000184, a Prodrug of the Potent Hepatitis B Virus Capsid Assembly Modulator ALG-001075.
Aligos Belgium BV
12
Selective Inhibition of Organic Cation Transporter 1 by Benzoylpaeoniflorin Attenuates Hepatic Lipid Accumulation through AMPK Activation.
Tianjin University
23
Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1.
University Medicine Greifswald
3
Cloning and functional expression of a human liver organic cation transporter.
University of California San Francisco
4
The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1.
University of California San Francisco
16
Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).
University of California
3
Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system.
University of California
2
Selectivity of the polyspecific cation transporter rOCT1 is changed by mutation of aspartate 475 to glutamate.
Bayerische Julius-Maximilians-Universit£T
10
A new chemotype inhibitor for the human organic cation transporter 3 (hOCT3).
Virginia Commonwealth University
63
Styryl quinazoline derivatives as pharmaceutically active agents
Vichem Chemie Kutató
37
Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
Kochi Medical School
14
Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes.
Universita Del Piemonte Orientale